Cargando…
More Than Meets the Eye: A Case of Breast Cancer Switching from Being Luminal-Androgen-Receptor-Positive to Being Hormone-Receptor-Positive
Triple-negative breast cancer (TNBC) represents about 15% of all breast cancers and is usually characterized by aggressive clinical behavior and a poor prognosis. Four TNBC subgroups have been previously defined with different molecular profiles: (i) luminal androgen receptor (LAR), (ii) mesenchymal...
Autores principales: | Martorana, Federica, Di Grazia, Giuseppe, Rosano, Giovanni Nunzio, Vecchio, Giada Maria, Conti, Chiara, Nucera, Sabrina, Magro, Gaetano, Vigneri, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608003/ https://www.ncbi.nlm.nih.gov/pubmed/37893593 http://dx.doi.org/10.3390/medicina59101875 |
Ejemplares similares
-
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
por: Stella, Stefania, et al.
Publicado: (2023) -
Being positive
por: Clayton, Mike
Publicado: (2017) -
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023) -
Expression of Androgen Receptor in Estrogen Receptor–positive Breast Cancer
por: Agrawal, Anil, et al.
Publicado: (2016) -
Being Positive about Selection
por: MacCallum, Catriona, et al.
Publicado: (2006)